Product Description

Tukavo 50 mg Tablet is a prescription medicine manufactured by Zydus Lifesciences Ltd. It is used in the treatment of advanced or metastatic HER2-positive breast cancer, especially in patients who have previously been treated with other HER2-directed therapies. This medicine is commonly prescribed in combination with trastuzumab and capecitabine. Tukavo contains tucatinib, a highly selective tyrosine kinase inhibitor that targets the HER2 receptor. It works by blocking the signals that promote the growth and spread of cancer cells. Tukavo is particularly effective in patients with brain metastases, as it can cross the blood-brain barrier and help manage central nervous system involvement. At Macarius Health, we ensure timely access to Tukavo 50 mg at competitive prices, so patients can benefit from cutting-edge treatments without compromise.